LIR Life Sciences Corp. (BBCMF)
OTCMKTS · Delayed Price · Currency is USD
1.000
+0.250 (33.33%)
At close: Feb 11, 2026
LIR Life Sciences Company Description
LIR Life Sciences Corp. operates as biopharmaceutical company that develops transdermal delivery system for obesity and metabolic disorders. The company was incorporated in 2024 and is based in Vancouver, Canada.
LIR Life Sciences Corp.
| Country | Canada |
| Founded | 2024 |
| Industry | Biotechnology |
| Sector | Healthcare |
| CEO | Edward Mills |
Contact Details
Address: 1505 W 2nd Ave Vancouver, BC V6J 1H2 Canada | |
| Phone | (888) 436 7772 |
| Website | lirlifesciences.com |
Stock Details
| Ticker Symbol | BBCMF |
| Exchange | OTCMKTS |
| Fiscal Year | May - April |
| Reporting Currency | CAD |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Dr. Edward Mills Ph.D. | Chief Executive Officer and Director |
| Harpreet Nijjar C.M.A., CPA | Chief Financial Officer, Corporate Secretary and Director |